LEE011 succinate hydrate Supplier & Distributor of CAS# 1231929-97-7

LEE011 succinate hydrate

Quantity:

add to inquiry

Product Description:

LEE011 succinate hydrate is a selective cyclin-dependent kinase inhibitor used in cancer therapy.

Applications & Uses:

CAS#:

1231929-97-7

SYNONYM:

Ribociclib succinate;NVP-LEE011;LEE011-free base;Kisqali

FORMULA:

C23H30N8O · C4H6O4 · xH2O

PRODUCT TYPE:

HAZARD:

Caution

CATEGORIES:

Pharmaceutical

Technical Specifications

Appearance :

White to off-white solid

Molecular weight, g/mol :

560.65

LEE011 succinate hydrate, known as ribociclib in the pharmaceutical industry, is a highly specific cyclin-dependent kinase inhibitor used primarily in the treatment of certain types of breast cancer. With a meticulously crafted molecular structure, this compound plays a critical role in disrupting cancer cell proliferation by targeting CDK4 and CDK6, enzymes crucial for cell cycle progression. Offering a therapeutic option for HR-positive, HER2-negative advanced or metastatic breast cancer, LEE011 succinate hydrate is frequently used in combination with endocrine therapies such as letrozole. Known for its optimal hydration state, the succinate hydrate formulation ensures enhanced stability and bioavailability, maximizing its efficacy in clinical applications. LEE011 succinate hydrate is an invaluable component in oncological treatment protocols, providing a targeted approach in the fight against cancer.

Details

CAS #

1231929-97-7

CATEGORIES:

Pharmaceutical

Having Trouble Finding A Specific Product?
We Will Find It For You!

GET A QUICK QUOTE NOW

Recent Searches

Trending Now

Markets

Process Point

Process Point, LLC.

500 Office Center Drive, Suite 803
Fort Washington, PA 19034
Phone: 855-453-6208

Email: hello@processpointchem.com

Your Product Inquiry

You have not added any products to your inquiry.

Click Here to search our product database.

Unsent Inquiries: